Applying Chemical Engineering Concepts to Toxicology

将化学工程概念应用于毒理学

基本信息

批准号：
6524834
负责人：
MICAELA B REDDY
金额：
$ 3万
依托单位：
COLORADO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2002
资助国家：
美国
起止时间：
2002-09-30 至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/6524834
关键词：
bioengineering /biomedical engineering biotransformation carcinogenesis chemical kinetics chemical models chemical related neoplasm /cancer dosage drug metabolism environmental toxicology human tissue inhalation drug administration laboratory rat model design /development pharmacokinetics polymers silicon compounds

项目摘要

Octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (DS) are common additives in personal care products. Both D4 and D5 are volatile, lipophilic chemicals that can be absorbed through the skin and lungs. Exposure to D4 has resulted in enzyme induction in the liver similar to that resulting from exposure to phenobarbital. Exposure to D5 has resulted in toxicity in the lung of the rat. However, it is not clear if these compounds will have similar effects in humans. To determine if these health effects are likely to occur in humans as well as rats, the mode of action of the compounds and the relationship between dose at the target tissue and response must be determined. As a first step to determining the mode of action and dose-response relationship, the major goal of this research project is to use chemical engineering methodolgies to develop physiologically based pharmacokinetic (PBPK) models for estimating D4 and D5 concentrations at the target tissue in both rats and humans. To achieve this goal, existing pharmacokinetic data for D4 and D5 distribution in the rat from the literature will be used in combination with PBPK model parameters measured experimentally (i.e., tissue:air and blood:air partition coefficients and kinetic constants for biotransformation). The resulting PBPK models for D4 and D5 distribution in humans can be used to assess the risk these compounds pose to humans.

八甲基环甲硅氧烷（D4）和decam-甲基环甲硅氧烷（DS）是个人护理产品中常见的添加剂。 D4和D5都是挥发性的亲脂化学物质，可以通过皮肤和肺部吸收。暴露于D4导致肝脏的酶诱导类似于暴露于苯巴比妥导致的酶。暴露于D5导致大鼠肺的毒性。但是，尚不清楚这些化合物在人类中是否会产生相似的作用。为了确定这些健康作用是否可能在人类和大鼠中发生，必须确定化合物的作用方式以及目标组织处的剂量与剂量之间的关系。作为确定作用方式和剂量响应关系的第一步，该研究项目的主要目标是使用化学工程方法来开发基于生理的药代动力学（PBPK）模型，以估计大鼠和人类目标组织的D4和D5浓度。为了实现这一目标，将使用文献中D4和D5分布的现有药代动力学数据与实验测量的PBPK模型参数（即组织：血液：空气和血液：空气分配系数和生物转换的动力学常数）结合使用。人类中D4和D5分布的最终PBPK模型可用于评估这些化合物对人的构成风险。